KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
KNTE
Delisted
KNTE was delisted on the 2nd of April, 2024.
62 hedge funds and large institutions have $891M invested in Kinnate Biopharma Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 20 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding
Funds holding: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
24% less capital invested
Capital invested by funds: $1.18B → $891M (-$286M)
Holders
62
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$15.7M | |
| 2 | +$9.2M | |
| 3 | +$2.31M | |
| 4 |
Morgan Stanley
New York
|
+$2.03M |
| 5 |
BlackRock
New York
|
+$1.47M |
Top Sellers
| 1 | -$7.79M | |
| 2 | -$4.73M | |
| 3 | -$4.44M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
-$3.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.73M |